1hw4

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1hw4.jpg|left|200px]]
[[Image:1hw4.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1hw4 |SIZE=350|CAPTION= <scene name='initialview01'>1hw4</scene>, resolution 2.06&Aring;
+
The line below this paragraph, containing "STRUCTURE_1hw4", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=CME:S,S-(2-HYDROXYETHYL)THIOCYSTEINE'>CME</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Thymidylate_synthase Thymidylate synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.1.1.45 2.1.1.45] </span>
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1hw4| PDB=1hw4 | SCENE= }}
-
|RELATEDENTRY=[[1hw3|1HW3]]
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1hw4 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hw4 OCA], [http://www.ebi.ac.uk/pdbsum/1hw4 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1hw4 RCSB]</span>
+
-
}}
+
'''STRUCTURE OF THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS'''
'''STRUCTURE OF THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS'''
Line 34: Line 31:
[[Category: Phan, J.]]
[[Category: Phan, J.]]
[[Category: Steadman, J D.]]
[[Category: Steadman, J D.]]
-
[[Category: methyltransferase]]
+
[[Category: Methyltransferase]]
-
[[Category: thymidylate synthase]]
+
[[Category: Thymidylate synthase]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 19:17:26 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:11:17 2008''
+

Revision as of 16:17, 2 May 2008

Template:STRUCTURE 1hw4

STRUCTURE OF THYMIDYLATE SYNTHASE SUGGESTS ADVANTAGES OF CHEMOTHERAPY WITH NONCOMPETITIVE INHIBITORS


Overview

Thymidylate synthase (TS) is a major target in the chemotherapy of colorectal cancer and some other neoplasms. The emergence of resistance to the treatment is often related to the increased levels of TS in cancer cells, which have been linked to the elimination of TS binding to its own mRNA upon drug binding, a feedback regulatory mechanism, and/or to the increased stability to intracellular degradation of TS.drug complexes (versus unliganded TS). The active site loop of human TS (hTS) has a unique conformation resulted from a rotation by 180 degrees relative to its orientation in bacterial TSs. In this conformation, the enzyme must be inactive, because the catalytic cysteine is no longer positioned in the ligand-binding pocket. The ordered solvent structure obtained from high resolution crystallographic data (2.0 A) suggests that the inactive loop conformation promotes mRNA binding and intracellular degradation of the enzyme. This hypothesis is supported by fluorescence studies, which indicate that in solution both active and inactive forms of hTS are present. The binding of phosphate ion shifts the equilibrium toward the inactive conformation; subsequent dUMP binding reverses the equilibrium toward the active form. Thus, TS inhibition via stabilization of the inactive conformation should lead to less resistance than is observed with presently used drugs, which are analogs of its substrates, dUMP and CH(2)H(4)folate, and bind in the active site, promoting the active conformation. The presence of an extension at the N terminus of native hTS has no significant effect on kinetic properties or crystal structure.

About this Structure

1HW4 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure of human thymidylate synthase suggests advantages of chemotherapy with noncompetitive inhibitors., Phan J, Steadman DJ, Koli S, Ding WC, Minor W, Dunlap RB, Berger SH, Lebioda L, J Biol Chem. 2001 Apr 27;276(17):14170-7. Epub 2001 Jan 24. PMID:11278511 Page seeded by OCA on Fri May 2 19:17:26 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools